BAKER BROS. ADVISORS LP 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-08 5:29 pm Purchase | 2024-10-04 | 13D | Kiniksa Pharmaceuticals, Ltd. KNSA | BAKER BROS. ADVISORS LP | 3,151,029 7.700% | 3,151,029 (New Position) | Filing |